The New Medicine Service (NMS) Toolkit, launched today by Pfizer Healthy Partnerships and endorsed by Pharmacy Voice and the Royal Pharmaceutical Society, aims to help community pharmacy teams support people with long term conditions by increasing their understanding of and engagement with their condition and medicines. The resources have been developed in direct response to feedback and requests for training and support that the Pfizer Healthy Partnerships team receives from the healthcare professionals they work with.
The New Medicine Service, introduced in 2011, provides an opportunity for community pharmacists to use their professional skills and medicines expertise to help patients make decisions about their treatment and self-management. Research has shown the NMS to significantly increase patients’ adherence to their new medicine, and that delivery of the service by community pharmacy will save the NHS money through better patient outcomes at overall reduced costs.
Commenting on the launch of these new resources, Pharmacy Voice Chief Executive Rob Darracott said:
“With the challenges currently facing the community pharmacy sector, providing practical support and assistance to frontline pharmacy teams has never been more important. After five years, the New Medicines Service is now a central part of community pharmacists’ daily work supporting medicines optimisation, patient safety and person-centred care. This new toolkit will help build confidence in those who are new to delivering the services while offering more experienced pharmacists a chance to take a look at their service from a fresh approach.”
The toolkit provides suggestions and advice on how to deliver the service and maximize the value to patients, and includes a set of communications materials to help pharmacy teams explain the benefits of the NMS to patients and other healthcare professionals.